OCTRU Trials Hub
@octructu.bsky.social
Oxford Clinical Trials Research Unit (OCTRU) is a UKCRC fully registered Clinical Trials Unit, based within the University of Oxford @ox.ac.uk
🌐 https://www.ndorms.ox.ac.uk/octru
🌐 https://www.ndorms.ox.ac.uk/octru
It's day 🔟 of our advent calendar! 📆 🎄
Today we introduce RAMBOH-1!
The RAMBOH-1 study is testing whether a type of drug called a RAMBA can increase retinoic acid levels & reduce inflammation in the base of the thumb joint of people with hand osteoarthritis.
🌐 www.ndorms.ox.ac.uk/octru/ramboh-1
Today we introduce RAMBOH-1!
The RAMBOH-1 study is testing whether a type of drug called a RAMBA can increase retinoic acid levels & reduce inflammation in the base of the thumb joint of people with hand osteoarthritis.
🌐 www.ndorms.ox.ac.uk/octru/ramboh-1
December 10, 2025 at 12:02 PM
It's day 🔟 of our advent calendar! 📆 🎄
Today we introduce RAMBOH-1!
The RAMBOH-1 study is testing whether a type of drug called a RAMBA can increase retinoic acid levels & reduce inflammation in the base of the thumb joint of people with hand osteoarthritis.
🌐 www.ndorms.ox.ac.uk/octru/ramboh-1
Today we introduce RAMBOH-1!
The RAMBOH-1 study is testing whether a type of drug called a RAMBA can increase retinoic acid levels & reduce inflammation in the base of the thumb joint of people with hand osteoarthritis.
🌐 www.ndorms.ox.ac.uk/octru/ramboh-1
It's day number 9️⃣ of our advent calendar! 📆 🎄
Today we introduce GEKO!🦎
@geko-study.bsky.social hopes to find out if a new treatment can help provide relief to people with knee osteoarthritis where simple treatments no longer work, but surgery isn’t yet necessary.
🌐 geko.octru.ox.ac.uk
Today we introduce GEKO!🦎
@geko-study.bsky.social hopes to find out if a new treatment can help provide relief to people with knee osteoarthritis where simple treatments no longer work, but surgery isn’t yet necessary.
🌐 geko.octru.ox.ac.uk
December 9, 2025 at 12:01 PM
It's day number 9️⃣ of our advent calendar! 📆 🎄
Today we introduce GEKO!🦎
@geko-study.bsky.social hopes to find out if a new treatment can help provide relief to people with knee osteoarthritis where simple treatments no longer work, but surgery isn’t yet necessary.
🌐 geko.octru.ox.ac.uk
Today we introduce GEKO!🦎
@geko-study.bsky.social hopes to find out if a new treatment can help provide relief to people with knee osteoarthritis where simple treatments no longer work, but surgery isn’t yet necessary.
🌐 geko.octru.ox.ac.uk
It's day number 8️⃣ of our advent calendar! 📆 🎄
Today we introduce WHiTE INITIATE!
The study aims to find out if more ward-based mobilisation activity after hip fracture surgery allows people to get home more quickly and allow them to stay living in their own home longer.
initiate.octru.ox.ac.uk
Today we introduce WHiTE INITIATE!
The study aims to find out if more ward-based mobilisation activity after hip fracture surgery allows people to get home more quickly and allow them to stay living in their own home longer.
initiate.octru.ox.ac.uk
December 8, 2025 at 12:05 PM
It's day number 8️⃣ of our advent calendar! 📆 🎄
Today we introduce WHiTE INITIATE!
The study aims to find out if more ward-based mobilisation activity after hip fracture surgery allows people to get home more quickly and allow them to stay living in their own home longer.
initiate.octru.ox.ac.uk
Today we introduce WHiTE INITIATE!
The study aims to find out if more ward-based mobilisation activity after hip fracture surgery allows people to get home more quickly and allow them to stay living in their own home longer.
initiate.octru.ox.ac.uk
It's day number 7️⃣ of our advent calendar! 📆 🎄
Today we introduce EndoNET!
The EndoNET study compares two treatment pathways for oestrogen receptor positive breast cancer in post-menopausal women who require surgery.
Find out more: www.nds.ox.ac.uk/research/sur...
Today we introduce EndoNET!
The EndoNET study compares two treatment pathways for oestrogen receptor positive breast cancer in post-menopausal women who require surgery.
Find out more: www.nds.ox.ac.uk/research/sur...
December 7, 2025 at 12:01 PM
It's day number 7️⃣ of our advent calendar! 📆 🎄
Today we introduce EndoNET!
The EndoNET study compares two treatment pathways for oestrogen receptor positive breast cancer in post-menopausal women who require surgery.
Find out more: www.nds.ox.ac.uk/research/sur...
Today we introduce EndoNET!
The EndoNET study compares two treatment pathways for oestrogen receptor positive breast cancer in post-menopausal women who require surgery.
Find out more: www.nds.ox.ac.uk/research/sur...
It's day number 6️⃣ of our advent calendar! 📆 🎄
Today we introduce LEADER!
Rheumatoid arthritis (RA) causes joint pain and swelling-the LEADER study is trying to find out the best way of using steroids which are routinely used to treat the symptoms of RA. 💊 💉
Find out more: leader.octru.ox.ac.uk
Today we introduce LEADER!
Rheumatoid arthritis (RA) causes joint pain and swelling-the LEADER study is trying to find out the best way of using steroids which are routinely used to treat the symptoms of RA. 💊 💉
Find out more: leader.octru.ox.ac.uk
December 6, 2025 at 12:01 PM
It's day number 6️⃣ of our advent calendar! 📆 🎄
Today we introduce LEADER!
Rheumatoid arthritis (RA) causes joint pain and swelling-the LEADER study is trying to find out the best way of using steroids which are routinely used to treat the symptoms of RA. 💊 💉
Find out more: leader.octru.ox.ac.uk
Today we introduce LEADER!
Rheumatoid arthritis (RA) causes joint pain and swelling-the LEADER study is trying to find out the best way of using steroids which are routinely used to treat the symptoms of RA. 💊 💉
Find out more: leader.octru.ox.ac.uk
It's day number 5️⃣ of our advent calendar! 📆 🎄
Today we introduce MILI
MILI is a clinical trial investigating the use of a drug called metformin as a way of reducing the cancer risk in people with Li Fraumeni Syndrome (LFS)
Find out more: mili.octru.ox.ac.uk
@octooxford.bsky.social
Today we introduce MILI
MILI is a clinical trial investigating the use of a drug called metformin as a way of reducing the cancer risk in people with Li Fraumeni Syndrome (LFS)
Find out more: mili.octru.ox.ac.uk
@octooxford.bsky.social
December 5, 2025 at 12:03 PM
It's day number 5️⃣ of our advent calendar! 📆 🎄
Today we introduce MILI
MILI is a clinical trial investigating the use of a drug called metformin as a way of reducing the cancer risk in people with Li Fraumeni Syndrome (LFS)
Find out more: mili.octru.ox.ac.uk
@octooxford.bsky.social
Today we introduce MILI
MILI is a clinical trial investigating the use of a drug called metformin as a way of reducing the cancer risk in people with Li Fraumeni Syndrome (LFS)
Find out more: mili.octru.ox.ac.uk
@octooxford.bsky.social
It's day number 4️⃣ of our advent calendar! 📆 🎄
Today we introduce ACL-STARR ⭐
The ACL STARR study is investigating which is the best surgical option for people who have torn their Anterior Cruciate Ligament (ACL) 🧎
Find out more about the study here:
aclstarr.com
@situ-oxford.bsky.social
Today we introduce ACL-STARR ⭐
The ACL STARR study is investigating which is the best surgical option for people who have torn their Anterior Cruciate Ligament (ACL) 🧎
Find out more about the study here:
aclstarr.com
@situ-oxford.bsky.social
December 4, 2025 at 12:02 PM
It's day number 4️⃣ of our advent calendar! 📆 🎄
Today we introduce ACL-STARR ⭐
The ACL STARR study is investigating which is the best surgical option for people who have torn their Anterior Cruciate Ligament (ACL) 🧎
Find out more about the study here:
aclstarr.com
@situ-oxford.bsky.social
Today we introduce ACL-STARR ⭐
The ACL STARR study is investigating which is the best surgical option for people who have torn their Anterior Cruciate Ligament (ACL) 🧎
Find out more about the study here:
aclstarr.com
@situ-oxford.bsky.social
It's day number 3️⃣ of our advent calendar! 📆 🎄
Today we look at our portfolio of open studies - thank you to all who are managing and working on our studies across all groups for their hard work in 2025 & for all our participants who are taking part! 🏥 🩺💊
Today we look at our portfolio of open studies - thank you to all who are managing and working on our studies across all groups for their hard work in 2025 & for all our participants who are taking part! 🏥 🩺💊
December 3, 2025 at 12:02 PM
It's day number 3️⃣ of our advent calendar! 📆 🎄
Today we look at our portfolio of open studies - thank you to all who are managing and working on our studies across all groups for their hard work in 2025 & for all our participants who are taking part! 🏥 🩺💊
Today we look at our portfolio of open studies - thank you to all who are managing and working on our studies across all groups for their hard work in 2025 & for all our participants who are taking part! 🏥 🩺💊
It's day number 2️⃣ of our advent calendar! 📆 🎄
OCTRU is a single UKCRC registered CTU comprised of mulitple trials groups working in different therapeutic areas: @octooxford.bsky.social, @situ-oxford.bsky.social (NDORMS & NDS), @oxtraumaresearch.bsky.social and Experimental Medicine and Rheumatology
OCTRU is a single UKCRC registered CTU comprised of mulitple trials groups working in different therapeutic areas: @octooxford.bsky.social, @situ-oxford.bsky.social (NDORMS & NDS), @oxtraumaresearch.bsky.social and Experimental Medicine and Rheumatology
December 2, 2025 at 12:04 PM
It's day number 2️⃣ of our advent calendar! 📆 🎄
OCTRU is a single UKCRC registered CTU comprised of mulitple trials groups working in different therapeutic areas: @octooxford.bsky.social, @situ-oxford.bsky.social (NDORMS & NDS), @oxtraumaresearch.bsky.social and Experimental Medicine and Rheumatology
OCTRU is a single UKCRC registered CTU comprised of mulitple trials groups working in different therapeutic areas: @octooxford.bsky.social, @situ-oxford.bsky.social (NDORMS & NDS), @oxtraumaresearch.bsky.social and Experimental Medicine and Rheumatology
Happy December and welcome to the OCTRU Advent Calendar 2025! 📆🎄
We hope that you can learn more about us and our studies throughout this festive period! 🌟☃️❄️
We hope that you can learn more about us and our studies throughout this festive period! 🌟☃️❄️
December 1, 2025 at 12:12 PM
Happy December and welcome to the OCTRU Advent Calendar 2025! 📆🎄
We hope that you can learn more about us and our studies throughout this festive period! 🌟☃️❄️
We hope that you can learn more about us and our studies throughout this festive period! 🌟☃️❄️
As we say hello to December, we celebrate @geko-study.bsky.social who achieved their best month of recruitment to date in November!
Thank you to everyone taking part in all of our studies, and to all of our study teams & sites.
@situ-oxford.bsky.social
Thank you to everyone taking part in all of our studies, and to all of our study teams & sites.
@situ-oxford.bsky.social
December 1, 2025 at 11:56 AM
As we say hello to December, we celebrate @geko-study.bsky.social who achieved their best month of recruitment to date in November!
Thank you to everyone taking part in all of our studies, and to all of our study teams & sites.
@situ-oxford.bsky.social
Thank you to everyone taking part in all of our studies, and to all of our study teams & sites.
@situ-oxford.bsky.social
Hello November! We start the month by congratulating the @forensic-uk.bsky.social , GEKO, MILI, ODDSOCKS & REACH studies who achieved their best month of recruitment to date in October! 👏
Thank you to everyone taking part in all of our studies, and to all of our study teams & sites.
Thank you to everyone taking part in all of our studies, and to all of our study teams & sites.
November 3, 2025 at 1:03 PM
Hello November! We start the month by congratulating the @forensic-uk.bsky.social , GEKO, MILI, ODDSOCKS & REACH studies who achieved their best month of recruitment to date in October! 👏
Thank you to everyone taking part in all of our studies, and to all of our study teams & sites.
Thank you to everyone taking part in all of our studies, and to all of our study teams & sites.
As we say hello to October, we celebrate the studies that achieved their best month of recruitment of all time in September!
LEADER
FORENSIC
Thank you to everyone taking part in our research & to our teams for their work across all of our studies!
LEADER
FORENSIC
Thank you to everyone taking part in our research & to our teams for their work across all of our studies!
October 1, 2025 at 1:53 PM
As we say hello to October, we celebrate the studies that achieved their best month of recruitment of all time in September!
LEADER
FORENSIC
Thank you to everyone taking part in our research & to our teams for their work across all of our studies!
LEADER
FORENSIC
Thank you to everyone taking part in our research & to our teams for their work across all of our studies!
We can't believe it's already September!
Well done to the LEADER study who achieved their best month of recruitment to date in August! 👏
Find out more about the study here: leader.octru.ox.ac.uk
& thank you to everyone taking part in all of our studies, and to all of our hardworking teams!
Well done to the LEADER study who achieved their best month of recruitment to date in August! 👏
Find out more about the study here: leader.octru.ox.ac.uk
& thank you to everyone taking part in all of our studies, and to all of our hardworking teams!
September 2, 2025 at 2:57 PM
We can't believe it's already September!
Well done to the LEADER study who achieved their best month of recruitment to date in August! 👏
Find out more about the study here: leader.octru.ox.ac.uk
& thank you to everyone taking part in all of our studies, and to all of our hardworking teams!
Well done to the LEADER study who achieved their best month of recruitment to date in August! 👏
Find out more about the study here: leader.octru.ox.ac.uk
& thank you to everyone taking part in all of our studies, and to all of our hardworking teams!
As we welcome August we celebrate the studies that acheieved their best month of recruitment to date in July!
Well done to the @sarongtrial.bsky.social, TaILOR, and INITIATE teams, and thank you to everyone taking part in, and working on, all of our studies! 👏
Well done to the @sarongtrial.bsky.social, TaILOR, and INITIATE teams, and thank you to everyone taking part in, and working on, all of our studies! 👏
August 1, 2025 at 11:00 AM
As we welcome August we celebrate the studies that acheieved their best month of recruitment to date in July!
Well done to the @sarongtrial.bsky.social, TaILOR, and INITIATE teams, and thank you to everyone taking part in, and working on, all of our studies! 👏
Well done to the @sarongtrial.bsky.social, TaILOR, and INITIATE teams, and thank you to everyone taking part in, and working on, all of our studies! 👏
The EXPLAIN Initiative has produced generic multilingual Explainer Animations for three key topics in clinical studies - available to use for free for studies at CTUs across the @ukcrc-ctu.org.uk network.
To find out more, and to request the use of the videos, visit explain.octru.ox.ac.uk
To find out more, and to request the use of the videos, visit explain.octru.ox.ac.uk
July 18, 2025 at 11:01 AM
The EXPLAIN Initiative has produced generic multilingual Explainer Animations for three key topics in clinical studies - available to use for free for studies at CTUs across the @ukcrc-ctu.org.uk network.
To find out more, and to request the use of the videos, visit explain.octru.ox.ac.uk
To find out more, and to request the use of the videos, visit explain.octru.ox.ac.uk
We had a brilliant Summer Meeting yesterday! 🌞
Great to hear from all our groups on their achievements and innovations, and from our guest speaker Adwoa Parker for an engaging and informative talk!
Congratulations also to the nominees and winners of our CTU awards for 2024!
Great to hear from all our groups on their achievements and innovations, and from our guest speaker Adwoa Parker for an engaging and informative talk!
Congratulations also to the nominees and winners of our CTU awards for 2024!
July 11, 2025 at 9:01 AM
We had a brilliant Summer Meeting yesterday! 🌞
Great to hear from all our groups on their achievements and innovations, and from our guest speaker Adwoa Parker for an engaging and informative talk!
Congratulations also to the nominees and winners of our CTU awards for 2024!
Great to hear from all our groups on their achievements and innovations, and from our guest speaker Adwoa Parker for an engaging and informative talk!
Congratulations also to the nominees and winners of our CTU awards for 2024!
Wow, WHiTE FRUITI recruited their 700th participant yesterday! 👏
Well done to the team and all involved in the study, and thank you to all our participants!
Find out more about the study here: www.ndorms.ox.ac.uk/research/cli...
@oxtraumaresearch.bsky.social
Well done to the team and all involved in the study, and thank you to all our participants!
Find out more about the study here: www.ndorms.ox.ac.uk/research/cli...
@oxtraumaresearch.bsky.social
July 3, 2025 at 9:39 AM
Wow, WHiTE FRUITI recruited their 700th participant yesterday! 👏
Well done to the team and all involved in the study, and thank you to all our participants!
Find out more about the study here: www.ndorms.ox.ac.uk/research/cli...
@oxtraumaresearch.bsky.social
Well done to the team and all involved in the study, and thank you to all our participants!
Find out more about the study here: www.ndorms.ox.ac.uk/research/cli...
@oxtraumaresearch.bsky.social
Well done to the PART, TaILOR and INITIATE study teams - they achieved their best month of recruitment to date in June! 👏
Thank you to everyone taking part across all of our studies and to all of our hardworking teams!
@situ-oxford.bsky.social @oxtraumaresearch.bsky.social
Thank you to everyone taking part across all of our studies and to all of our hardworking teams!
@situ-oxford.bsky.social @oxtraumaresearch.bsky.social
July 1, 2025 at 10:24 AM
Well done to the PART, TaILOR and INITIATE study teams - they achieved their best month of recruitment to date in June! 👏
Thank you to everyone taking part across all of our studies and to all of our hardworking teams!
@situ-oxford.bsky.social @oxtraumaresearch.bsky.social
Thank you to everyone taking part across all of our studies and to all of our hardworking teams!
@situ-oxford.bsky.social @oxtraumaresearch.bsky.social
A huge well done to the TaILOR study team - they have recruited over 100 participants! 👏
Thank you to everyone taking part in this study & for the hard work of all involved!
Find out more about the study here: tailor.octru.ox.ac.uk/node/523
#Rheumatology #InflammatoryArthritis
Thank you to everyone taking part in this study & for the hard work of all involved!
Find out more about the study here: tailor.octru.ox.ac.uk/node/523
#Rheumatology #InflammatoryArthritis
June 30, 2025 at 2:10 PM
A huge well done to the TaILOR study team - they have recruited over 100 participants! 👏
Thank you to everyone taking part in this study & for the hard work of all involved!
Find out more about the study here: tailor.octru.ox.ac.uk/node/523
#Rheumatology #InflammatoryArthritis
Thank you to everyone taking part in this study & for the hard work of all involved!
Find out more about the study here: tailor.octru.ox.ac.uk/node/523
#Rheumatology #InflammatoryArthritis
Well done to OP NON STOP, ROBUST, and TaILOR - these studies achieved their best month of recruitment to date in May!
Thank you to everyone taking part across all of our studies and to everyone involved in/contributing to our research! 👏
@oxtraumaresearch.bsky.social @situ-oxford.bsky.social
Thank you to everyone taking part across all of our studies and to everyone involved in/contributing to our research! 👏
@oxtraumaresearch.bsky.social @situ-oxford.bsky.social
June 2, 2025 at 10:42 AM
Well done to OP NON STOP, ROBUST, and TaILOR - these studies achieved their best month of recruitment to date in May!
Thank you to everyone taking part across all of our studies and to everyone involved in/contributing to our research! 👏
@oxtraumaresearch.bsky.social @situ-oxford.bsky.social
Thank you to everyone taking part across all of our studies and to everyone involved in/contributing to our research! 👏
@oxtraumaresearch.bsky.social @situ-oxford.bsky.social